CONMED Corp (CNMD)
NYSE · Instruments & Medical Devices · Electromedical & Electrotherapeutic Apparatus
- Price
- $45.18
- Day
- -1.35%
- Market cap
- $1.35B
- P/E
- 21.1
Close 2026-09-24.
The company
General CONMED Corporation was incorporated under the laws of the State of New York in 1970 and became a Delaware corporation in May 2020. CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. The Company’s 3,900 employees distribute its products worldwide from three primary manufacturing locations. Our headquarters are located in Largo, Florida. We have historically used strategic business acquisitions, internal product development and distribution relationships to diversify our product offerings, increase our market share in certain product lines, realize economies of scale and take advantage of growth opportunities in the healthcare field. We are committed to offering products with the highest standards of quality, technological excellence and customer service. Substantially all of our facilities have attained certification under the International Organization for Standardization ("ISO") international quality standards and other domestic and international quality accreditations.
From Item 1: General.
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- BlackRock, Inc. — $112.36M
- EARNEST PARTNERS LLC — $82M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $71.64M
- FULLER & THALER ASSET MANAGEMENT, INC. — $51.71M
- STATE STREET CORP — $46.39M
- VANGUARD CAPITAL MANAGEMENT LLC — $44.37M
- DIMENSIONAL FUND ADVISORS LP — $41.01M
- SEI INVESTMENTS CO — $32.32M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Glaze Richard (Chief Information Officer) sold 257 shares at $41.21 on 2025-11-21
- Garner Todd W (Executive Vice President & CFO) sold 3,500 shares at $43.00 on 2025-11-06
- Farkas Charles (Director) sold 1,103 shares at $53.54 on 2025-09-12
- Farkas Charles (Director) sold 897 shares at $53.51 on 2025-09-12
- Garner Todd W (Executive Vice President & CFO) sold 598 shares at $52.45 on 2025-08-07
- Farkas Charles (Director) sold 4,000 shares at $56.94 on 2025-05-05
Recent filings
- 4 — 2026-09-10
- 10-Q — 2026-07-29
- 8-K — 2026-07-29
- 4 — 2026-07-17
- 3 — 2026-07-17
- 4 — 2026-07-02
- 4 — 2026-07-02
- 3 — 2026-07-02
- 3 — 2026-07-02
- 8-K — 2026-06-17